发明名称 HETEROCYCLIC COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a compound exhibiting HDS1-inhibiting actions or the like that is useful as a prophylactic or therapeutic agent for pathology in which a glucocorticoid participates, for example, metabolic diseases such as diabetes, insulin resistance, diabetic complications, obesity, hyperlipidemia, hypertension or fatty liver, or the like, and its applications. SOLUTION: The prophylactic or therapeutic agent for pathology in which a glucocorticoid participates or an 11βHSD1-inhibiting agent comprises a compound represented by general formula [1'] or a salt thereof. In the formula, the ring A, R<SP>2</SP>, R<SP>3</SP>, R<SP>4</SP>and X are each defined specifically. COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2007332034(A) 申请公布日期 2007.12.27
申请号 JP20060159336 申请日期 2006.06.08
申请人 JAPAN TOBACCO INC 发明人 YAMAMOTO HIROSHI;OE YASUHIRO;GOTO HIROYUKI;HARADA KAZUTO;YADA SHINJI;NISHIU ATSUSHI;KAKUTANI MAKOTO;FUJII SHUNSUKE;ASAHINA KOTA;ITO TAKASHI
分类号 C07D401/14;A61K31/4155;A61K31/454;A61K31/4545;A61K31/496;A61K31/497;A61K31/506;A61K31/538;A61K31/541;A61K31/55;A61P1/16;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/46;A61P9/10;A61P9/12;A61P19/10;A61P25/18;A61P25/28;A61P27/06;A61P37/04;A61P43/00;C07D403/06;C07D403/14;C07D409/14;C07D413/14;C07D417/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址